Mumbai, India—Two newer techniques offer potential to improve the experience for patients undergoing percutaneous nephrolithotomy, according to separate presentations made at the World Congress on Endourology. One study focused on using a plastic model for visualization purposes before operating on complex renal stones, and the other examined the effectiveness of a hemostatic gelatin matrix to seal the percutaneous nephrostomy tract.
San Francisco—New contralateral vesicoureteral reflux occurs more often than previously thought following endoscopic treatment of unilateral VUR and may warrant further treatment, according to a report presented at the American Academy of Pediatrics Section on Urology meeting here.
Mumbai, India—More and more urologists are investing in heat-based treatment systems for BPH, and Thayne Larson, MD, a staff member with the Institute of Medical Research in Scottsdale, AZ, wants to make sure they're being smart shoppers.
San Francisco—Endoscopic therapy for vesicoureteral reflux has a high success rate and a low risk of obstruction compared with open surgery, but multiple treatments may be necessary to achieve a cure, results of a meta-analysis of published studies indicate.
Mumbai, India—Rates of surgical and medical therapy for BPH at the county and state levels show significant systematic variation, according to Duke University researchers, who reported their findings during a presentation at the World Congress on Endourology here.
Boston—Findings from analyses of data collected in three large, prospectively followed cohorts show that obesity and weight gain increase the risk of kidney stone formation in younger and older adult men and women, according to recently published research from Brigham and Women's Hospital, Harvard Medical School, Boston.
San Antonio—A study showing that PSA levels appear to have an inverse relationship with body mass index does no harm to the value of the screening test, says Ian M. Thompson, Jr, MD, one of the study's principal authors. Rather, it provides further evidence that PSA cutoffs alone may not best estimate a man's risk of prostate cancer.
New AUA clinical guidelines on the management of staghorn calculi recommend that most patients with staghorn stones should have percutaneous nephrolithotomy as initial treatment.
ACMI Corp. said it has created a Gynecology and Surgical Specialties business unit to concentrate on growth opportunities in women's health and other key surgical specialties.
Introduction this month of the Men's Health Act would create an Office of Men's Health at the Department of Health & Human Services.
Total operating costs are lower in larger ambulatory surgery centers than in smaller ones, according to a newly released Medical Group Management Association survey.
Pfizer and software giant Microsoft have filed parallel lawsuits against web site operators and spam advertisers that sell illegal "generic" versions of sildenafil citrate (Viagra).
Stevan B. Streem, MD, who developed minimally invasive methods for treating renal blockage and calculi, died Feb. 5, 2005, of complications from melanoma.
Diabetes appears to be associated with a reduced risk of prostate cancer, according to an article in the American Journal of Epidemiology (2005; 161:147-52).
New AUA clinical guidelines on the management of staghorn calculi recommend that most patients with staghorn stones should have percutaneous nephrolithotomy as initial treatment.
A point-of-care bladder cancer test (NMP22 BladderChek, Matritech, Newton, MA) increases the accuracy of cystoscopy, according to results of a large, multicenter study published in this week's JAMA (2005; 293:810-6).
The Centers for Medicare & Medicaid Services has expanded coverage for the use of positron emission tomography for evaluating patients with testicular cancer and several other cancers.
Abbott's UroVysion DNA probe assay has been approved by the FDA for use as an aid in initial diagnosis of bladder cancer in patients with hematuria and suspected of having bladder cancer.
A chemical used in certain types of plastic may stimulate growth of a specific category of prostate cancer cells, according a study in Cancer Research (2005; 65:54-65).
Newly released data add further evidence that erectile dysfunction may be the earliest sign of a more significant cardiovascular problem (The Journal of Sexual Medicine 2005; 2:40-50).
Eli Lilly said it has withdrawn its new drug application for duloxetine hydrochloride for the treatment of stress urinary incontinence.
Certain mutations in the androgen receptor protein appear to cause advanced and invasive prostate cancer, at least in a mouse model, according to a recent study in the Proceedings of the National Academy of Sciences (2005; 102:1151-6).
Kidney stone formation is influenced by obesity and weight gain, especially in women, according to a study published in last week's JAMA (2005; 293:455-62).
Mumbai, India--Technical advances in laparoscopic radical prostatectomy continue to improve the safety and efficacy of the procedure, according to a number of reports from the World Congress on Endourology here.
Physical therapy, perineural injections may provide relief without surgery, experts say
Will leuprolide acetate (Lupron) reimbursement fall by 20% in 2005? When will it take place? And what will the reimbursement be?
In general, we recommend cryoablation for patients with localized, high-grade tumors and higher-volume disease who are not potent or not interested in maintaining their potency.
Recovering valuable data when those drives crash or burn—and counseling clients in crisis—has become a $20 million-a-year industry.
Buenos Aires, Argentina--For men with Peyronie's disease with or without erectile dysfunction, intralesional interferon alfa-2b (Intron-A) may offer a simple, safe, and effective treatment for improving penile curvature and the ability to have sexual intercourse. So say Cleveland Clinic researchers, who presented the results of a study on the drug in this population at the International Society for Sexual and Impotence Research world congress here.
